rs377535841
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 5P and 5B. PM5PP2PP3_ModerateBP6BS2
The NM_017780.4(CHD7):c.3973T>C(p.Tyr1325His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000166 in 1,613,522 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y1325D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_017780.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHD7 | NM_017780.4 | c.3973T>C | p.Tyr1325His | missense_variant | 16/38 | ENST00000423902.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHD7 | ENST00000423902.7 | c.3973T>C | p.Tyr1325His | missense_variant | 16/38 | 5 | NM_017780.4 | P1 | |
CHD7 | ENST00000524602.5 | c.1717-25962T>C | intron_variant | 1 | |||||
CHD7 | ENST00000695853.1 | c.3973T>C | p.Tyr1325His | missense_variant, NMD_transcript_variant | 16/37 |
Frequencies
GnomAD3 genomes ? AF: 0.000131 AC: 20AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000684 AC: 17AN: 248596Hom.: 0 AF XY: 0.0000815 AC XY: 11AN XY: 134928
GnomAD4 exome AF: 0.000170 AC: 248AN: 1461344Hom.: 0 Cov.: 31 AF XY: 0.000179 AC XY: 130AN XY: 726918
GnomAD4 genome ? AF: 0.000131 AC: 20AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74354
ClinVar
Submissions by phenotype
not provided Uncertain:4Benign:2
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | CHD7: PP3, BS2 - |
Uncertain significance, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 27, 2020 | Reported in an individual with normosmic congenital hypogonadotropic hypogonadism and an individual with atrial ventricular septal defects (D'Alessandro et al., 2016; Cassatella et al., 2018); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 32724172, 31200363, 25996639, 29419413) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 26, 2018 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The CHD7 p.Tyr1325His variant was identified in 1 of 162 proband chromosomes (frequency: 0.0062) from individuals with atrioventricular septal defect (AVSD) (D'Alessandro_2016_PMID:25996639). The variant was also identified in dbSNP (ID: rs377535841), ClinVar (classified as a VUS by EGL Genetics and Invitae) and LOVD 3.0. The variant was also identified in control databases in 19 of 279988 chromosomes at a frequency of 0.000068 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Other in 1 of 7114 chromosomes (freq: 0.000141), European (non-Finnish) in 17 of 128040 chromosomes (freq: 0.000133) and Latino in 1 of 35274 chromosomes (freq: 0.000028), while the variant was not observed in the African, Ashkenazi Jewish, East Asian, European (Finnish), and South Asian populations. The p.Tyr1325 residue is conserved in mammals but not in more distantly related organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing at the variant location. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Hypogonadotropic hypogonadism 5 with or without anosmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
CHD7-related condition Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 07, 2024 | The CHD7 c.3973T>C variant is predicted to result in the amino acid substitution p.Tyr1325His. This variant has been previously reported in an individual with atrioventricular septum defect (D'Alessandro et al. 2016. PubMed ID: 25996639), and an individual with congenital hypogonadotropic hypogonadism (Table S2, Cassatella et al. 2018. PubMed ID: 29419413). An alternate nucleotide change affecting the same amino acid (c.3973T>G; p.Tyr1325Asp) has been observed in a cohort of individuals with CHARGE syndrome (Bergman et al. 2011. PubMed ID: 20884005), and reported as de novo (Table S1, Bergman et al. 2012. PubMed ID: 22539353). This variant is reported in 0.013% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
CHARGE association Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at